Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1200/week)
Manufacturing
(599/week)
Energy
(441/week)
Technology
(1143/week)
Other Manufacturing
(389/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Naltrexone
May 21, 2019
Coming Soon, the LDN 2019 Conference in Portland Oregon June 7-9th
May 01, 2019
Community Medical Services: Wisconsin's First Ever 24/7-accessible Opioid Treatment Program (OTP) Opens in West Allis
Mar 28, 2019
Baymark Health Services Opens Two AppleGate Recovery Clinics in Ohio
Mar 27, 2019
Baymark Health Services Opens Applegate Recovery in Thibodaux, LA
Feb 12, 2019
Addiction Medicine Practice Opens its 1st Opioid and Alcohol Treatment Center in Northern VA
Jan 30, 2019
BayMark Health Services Opens Opioid Addiction Treatment Center Near Denver
Jan 16, 2019
Alkermes Announces Recipients of 1st Annual ALKERMES PATHWAYS RESEARCH AWARDS (SM) Program
Dec 07, 2018
More Effective Treatment Options for Addiction on Horizon
Nov 28, 2018
Buvidal® Weekly and Buvidal® Monthly (CAM2038) Approved in Australia as the First Long-acting Treatment of Opioid Dependence
Nov 22, 2018
Camurus Receives EU Approval for Weekly and Monthly Buvidal® (CAM2038) for Opioid Dependence
Nov 07, 2018
Baymark Health Services Opens Applegate Recovery in Baton Rouge
Sep 07, 2018
FDA approves new dosage strength of buprenorphine and naloxone sublingual film as maintenance treatment for opioid dependence
Aug 14, 2018
Wide Variation across the Nation in Treatment for Opioid Abuse and Dependence
Aug 06, 2018
FDA takes new steps to encourage the development of novel medicines for the treatment of opioid use disorder
Jul 20, 2018
Coleman Institute Withdrawal Management Covered By Anthem Virginia
May 16, 2018
FDA Approves US WorldMeds' LUCEMYRA(TM) (lofexidine) After Priority Review for the Management of Opioid Withdrawal Symptoms
May 16, 2018
FDA approves the first non-opioid treatment for management of opioid withdrawal symptoms in adults
Apr 20, 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder
Apr 20, 2018
FDA takes new steps to advance the development of innovative products for treating opioid use disorder
Mar 23, 2018
Data Shows That the Global Addiction Treatment Market is Set to Grow
‹‹
Page 2
››
Latest News
May 24, 2025
Sunnova Receives NYSE Notice Regarding Delayed Form 10-Q Filing
May 24, 2025
Sable Offshore Corp. Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of...
May 24, 2025
Bentley Systems, Incorporated Declares Second Quarter 2025 Dividend
May 24, 2025
Peak Technology Acquires Jinxbot, Expanding Additive Manufacturing Capabilities for Deep Tech OEMs
May 24, 2025
Water Quality Reports Show Excellent Results for California American Water Customers
May 24, 2025
Soho Apparel Group Rallies Behind Trump’s Made-in-America Agenda, Unveils Aggressive U.S. Manufacturing...
May 24, 2025
U. S. Steel and the University of Michigan Solar Car Team Drive Sustainable Transportation
May 24, 2025
Intertribal Agriculture Council calls for Farm Bill reauthorization to support Tribal Nations, agricultural...
View all News
Agenda
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events